What longitudinal studies track ADHD development in preterm children?

PostedAugust 21, 2025

UpdatedSeptember 4, 2025

ByMy Patient Advice

Author: Avery Lombardi, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Longitudinal studies play a crucial role in understanding the development of ADHD in preterm children. These studies provide valuable insights into how ADHD symptoms emerge and evolve in children born prematurely. The development tracking of preterm children helps to identify early warning signs, assess the long-term impact of prematurity on attention and behaviour, and inform early intervention strategies.

Longitudinal studies are essential in mapping out the ADHD timeline from infancy to adolescence. These studies not only track the onset of ADHD symptoms but also explore how these symptoms progress over time and how early interventions might help mitigate their effects.

Key Longitudinal Studies on ADHD Development in Preterm Children

Here’s a breakdown of some important longitudinal studies that track the development tracking of ADHD in preterm children:

The ELGAN Study (Extremely Low Gestational Age Newborns Study)

The ELGAN study is one of the largest longitudinal studies tracking the development of ADHD in children born extremely preterm (before 28 weeks of gestation). The study tracks brain development, cognitive abilities, and behavioural issues in children born at very low birth weights.

The Premature Birth and ADHD Development Study

This studyfocuses on children born between 24 and 32 weeks’ gestation, tracking their ADHD timeline from infancy through childhood. The research examines cognitive, emotional, and behavioural development, assessing the onset of ADHD symptoms as children grow. This study provides key insights into the long-term effects of premature birth on attention, impulse control, and executive functioning.

The Chicago Longitudinal Study

This study has followed a cohort of low-birth-weight children to examine how early risk factors like prematurity can affect ADHD development. The study tracks a range of developmental milestones, including academic performance and social behaviour, and provides critical data on how prematurity influences ADHD in the long term.

The UK Millennium Cohort Study

The UK Millennium Cohort Study tracks the health and development of children born in the UK, including those born prematurely. This study provides a broader context for ADHD development tracking, looking at various socioeconomic, environmental, and genetic factors.

The Finnish Preterm Study

This study from Finland specifically looks at children born at 32 weeks of gestation or earlier and tracks the development tracking of ADHD symptoms. Researchers in this study assess both behavioural and cognitive challenges faced by these children and follow them into adolescence to study the persistence of ADHD symptoms and associated cognitive difficulties.

Long-term impact of prematurity on ADHD symptoms

Across all longitudinal studies, one consistent finding is that preterm children are more likely to develop ADHD symptoms, especially those born at very low birth weights or those who experienced neonatal complications.

Genetic and environmental factors in ADHD development

Many of these longitudinal studies also examine the interplay between genetic predispositions and environmental influences, such as prenatal care, socioeconomic factors, and early childhood experiences. ]

By understanding the findings from these longitudinal studies, we can better predict the developmental trajectory of ADHD in preterm children and implement interventions at critical stages. Early diagnosis and ongoing support can significantly improve the quality of life for these children as they grow.

Visit providers like ADHD Certify for personal consultations and tailored guidance.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to premature birth or low birth weight.

Avery Lombardi, MSc

Author

Avery Lombardi is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Psychology. She has professional experience in psychological assessment, evidence-based therapy, and research, working with both child and adult populations. Avery has provided clinical services in hospital, educational, and community settings, delivering interventions such as CBT, DBT, and tailored treatment plans for conditions including anxiety, depression, and developmental disorders. She has also contributed to research on self-stigma, self-esteem, and medication adherence in psychotic patients, and has created educational content on ADHD, treatment options, and daily coping strategies.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.